Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP

Last updated on 2021-10-08 History
Report ID 136585
Drug Identification Number 02244475
Brand name DIPYRIDAMOLE INJECTION, USP
Common or Proper name Dipyridamole Injection, USP 5 mg/mL SD Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) DIPYRIDAMOLE
Strength(s) 5MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-04-30
Actual start date
Estimated end date 2021-10-01
Actual end date 2021-10-01
Shortage status Resolved
Updated date 2021-10-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-10-08 French Compare
v9 2021-10-08 English Compare
v8 2021-10-01 French Compare
v7 2021-10-01 English Compare
v6 2021-10-01 English Compare
v5 2021-06-04 French Compare
v4 2021-06-04 English Compare
v3 2021-05-01 English Compare
v2 2021-03-31 French Compare
v1 2021-03-31 English Compare

Showing 1 to 10 of 10